Abstract: The present invention relates to new polymorphic forms of Crystalline Rosuvastatin calcium along with novel processes for crystalline as well as amorphous Rosuvastatin calcium.

Abstract: The present invention relates to new polymorphic forms of Crystalline Rosuvastatin calcium along with novel processes for crystalline as well as amorphous Rosuvastatin calcium.

Abstract: A method for the preparation of montelukast acid sodium salt thereof in amorphous form has been described. The method comprises of following steps: (a) generating the dilithium dianion of 1-(mercaptomethyl)cyclopropane acetic acid, by reacting with alkyl lithium, (b) coupling the said dianion with wet mesylate to get montelukast acid in crude form, (c) obtaining DCHA salt in crude form by adding dicyclohexylamine (DCHA) to crude acid obtained in the above step (b), (d) purifying and converting the said DCHA salt in crude form, to montelukast acid in pure form, and (e) reacting the pure montelukast acid in a polar protic solvent with a source of sodium ion followed by evaporating the solvent and triturating of the residue with non-polar water immiscible solvent.

Abstract: A system and method for preventing fraud in an online transaction is shown. Requests for financial transactions between on-line account holders are detected as well as relationships between the accounts. A fraud value related to a likelihood that a fraud is occurring in the transactions is determined based on the relationship. An indication of a likelihood of fraud is provided if the fraud value exceeds a predetermined amount. Thus the transaction is terminated and the appropriate parties are automatically notified.

Abstract: Improved process for the preparation of amorphous atorvastatin calcium salt (2:1) comprises hydrolyzing the lactone form of atorvastatin of formula of FIG. 1 with aqueous alkali or alkaline earth metal base, extracting with organic solvent the reaction mixture and adding the same to an anti-solvent to precipitate the product and finally filtering the product to afford amorphous atorvastatin calcium (2:1). The process also comprises the preparation of amorphous atorvastatin calcium salt (2:1) from its crystalline form.

Abstract: A method for the preparation of montelukast acid sodium salt thereof in amorphous form has been described. The method comprises of following steps: (a) generating the dilithium dianion of 1-(mercaptomethyl)cyclopropane acetic acid, by reacting with alkyl lithium, (b) coupling the said dianion with wet mesylate to get montelukast acid in crude form, (c) obtaining DCHA salt in crude form by adding dicyclohexylamine (DCHA) to crude acid obtained in the above step (b), (d) purifying and converting the said DCHA salt in crude form, to montelukast acid in pure form, and (e) reacting the pure montelukast acid in a polar protic solvent with a source of sodium ion followed by evaporating the solvent and triturating of the residue with non-polar water immiscible solvent.

Abstract: Atorvastatin calcium Form VI Or hydrates thereof, characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation of the same.

Abstract: An improved process for the production of Desloratadine is described wherein Loratadine is reacted with neat alcohol in presence of inorganic base, followed by isolating Desloratadine on addition of excess water in crystalline form.

Abstract: Improved process for the preparation of amorphous atorvastatin calcium salt (2:1) comprises hydrolyzing the lactone form of atorvastatin of formula of FIG. 1 with aqueous alkali or alkaline earth metal base, extracting with organic solvent the reaction mixture and adding the same to an anti-solvent to precipitate the product and finally filtering the product to afford amorphous atorvastatin calcium (2:1). The process also comprises the preparation of amorphous atorvastatin calcium salt (2:1) from its crystalline form.

Abstract: A scalable software architecture (20) for business computer platforms implements a messaging platform (FIG. 3) for communicating messages among various dynamically connected components, preferably including a communication gateway (28) for communication with at least one external media channel (52-62), a data manager layer (22) for maintaining data in a connected database system (40), and a business workflow engine (26) for implementing predetermined business workflows leveraging customized business logic and business software objects (22). The messaging platform comprises a managing process (502) and at least one agent process (504) forming a serial chain for distributed port number assignments and implementing client registration (Table 1) for robust, reliable messaging.

Abstract: The present invention relates to a workflow and workflow engine. A workflow in accordance with the present invention is a process that gets triggered in response to a predetermined event in a relationship management system. The event could be anything input into the system, such as an incoming interaction like a phone call, a fax, an e-mail, or a web-form submission. In addition an event could be a business events such as an overdue task, an inventory update, a merchandise sale, or an equipment order. A workflow is preferably characterized in terms of a set of steps the workflow is to perform, such as creating or modifying a business object, creating and sending an email or fax, making a decision based on a query, scheduling a timed event, and so on.